The Valley Desk

ArticleJournal of osteoporosisPublished

Cardiovascular Outcomes Following Therapeutic Sclerostin Inhibition Compared With Alternative Anabolic Therapies: A Real-World Propensity Score-Matched Analysis

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Jefferson Einstein Philadelphia Hospital, with Jefferson Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Journal of osteoporosis
Published
Subject terms
Osteoporosis; Sclerostin; Mace; Cardiovascular Safety; Romosozumab; Evenity
PubMed ID
42535103
PubMed Central ID
PMC13422644
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal